Canada Markets closed

Filament Health Corp. (FLHLF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1047+0.0023 (+2.25%)
At close: 01:40PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.1024
Open0.1047
BidN/A x N/A
AskN/A x N/A
Day's Range0.1047 - 0.1047
52 Week Range0.0808 - 0.3680
Volume100
Avg. Volume5,926
Market Cap17.25M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    KCSA Psychedelics Virtual Investor Conference Presentations Now Available for On-Demand Viewing

    NEW YORK, April 29, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the April 27th and 28th KCSA Psychedelics Virtual Investor Conference are now available for on-demand viewing. REGISTER OR LOGIN NOW AT: https://bit.ly/3OGHgD4 The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor materials from the company’s resource section. Comp

  • CNW Group

    FILAMENT HEALTH ANNOUNCES FOURTH PATENT ISSUANCE

    Filament Health Corp. (OTCQB:FLHLF) (NEO:FH) (FSE:7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company, today announced that it has been issued a fourth patent for the extraction and standardization of natural psilocybin and associated psychedelic compounds. Filament's latest patent was issued by the Canadian Intellectual Property Office (CIPO) and describes essential technology for transforming variable psychedelic raw materials into pharmaceutical-g

  • GlobeNewswire

    KCSA Psychedelics Virtual Investor Conference Agenda Announced for April 27th & 28th

    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, April 25, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, in partnership with KCSA Strategic Communications (“KCSA”), today announced the agenda for the upcoming KCSA Psychedelics Virtual Investor Conference to be held on April 27-28, 2022. Individual investors, institutional investors, advisors, and analysts are invited to attend this tw